The Effects of Selective Inhibition of Histone Deacetylase 1 and 3 in Huntington's Disease Mice.

Hecklau, Katharina; Mueller, Susanne; Koch, Stefan Paul; Mehkary, Mustafa Hussain; Kilic, Busra; Harms, Christoph; Boehm-Sturm, Philipp; Yildirim, Ferah

Hecklau, Katharina; Mueller, Susanne; Koch, Stefan Paul; Mehkary, Mustafa Hussain; Kilic, Busra; Harms, Christoph; Boehm-Sturm, Philipp; Yildirim, Ferah.

Afiliação

Hecklau K; Department of Neuropsychiatry, Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Mueller S; NeuroCure Cluster of Excellence, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Koch SP; NeuroCure Cluster of Excellence, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Mehkary MH; Department of Experimental Neurology, Center for Stroke Research Berlin (CSB), Charité - Universitätsmedizin Berlin, Berlin, Germany.
Kilic B; Charité Core Facility 7T Experimental MRIs, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Harms C; Department of Experimental Neurology, Center for Stroke Research Berlin (CSB), Charité - Universitätsmedizin Berlin, Berlin, Germany.
Boehm-Sturm P; Charité Core Facility 7T Experimental MRIs, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Yildirim F; Department of Neuropsychiatry, Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Front Mol Neurosci ; 14: 616886, 2021.

Article em En | MEDLINE | ID: mdl-33679321

Palavras-chave

HDAC inhibition; Huntington's disease; R6/1 mouse model; RGFP109; transcriptional dysregulation; volumetric MRI

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Mol Neurosci Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google